ketanserin has been researched along with sl 327 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blake, BL; Breese, GR; Knapp, DJ; Papadeas, ST | 1 |
1 other study(ies) available for ketanserin and sl 327
Article | Year |
---|---|
Sustained extracellular signal-regulated kinase 1/2 phosphorylation in neonate 6-hydroxydopamine-lesioned rats after repeated D1-dopamine receptor agonist administration: implications for NMDA receptor involvement.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aminoacetonitrile; Animals; Animals, Newborn; Benzazepines; Corpus Striatum; Cyclic AMP Response Element-Binding Protein; Dopamine Agonists; Dopamine Antagonists; Enzyme Inhibitors; Female; Ketanserin; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nerve Tissue Proteins; Nucleus Accumbens; Oxidopamine; Phosphorylation; Prefrontal Cortex; Protease Inhibitors; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate; Serotonin 5-HT2 Receptor Antagonists | 2004 |